Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Fatima H Karzai"'
Autor:
Kathleen Kelly, Eva Corey, William L. Dahut, Fatima H. Karzai, Aian Neil Alilin, JuanJuan Yin, Kerry M. McGowen, Qi Yang, Keith H. Jansson, Supreet Agarwal, Adam G. Sowalsky, Holly M. Nguyen, Crystal Tran, Caitlin M. Tice, Michael L. Beshiri
Tables of compounds, recombinant proteins, antibodies, and primers used
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b1955754f2f32f5c01080606f8dc1be
https://doi.org/10.1158/1078-0432.22469744
https://doi.org/10.1158/1078-0432.22469744
Autor:
Kathleen Kelly, Eva Corey, William L. Dahut, Fatima H. Karzai, Aian Neil Alilin, JuanJuan Yin, Kerry M. McGowen, Qi Yang, Keith H. Jansson, Supreet Agarwal, Adam G. Sowalsky, Holly M. Nguyen, Crystal Tran, Caitlin M. Tice, Michael L. Beshiri
Supplementary Figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b139c4ded5a1ba9f503a018219b1c015
https://doi.org/10.1158/1078-0432.22469747.v1
https://doi.org/10.1158/1078-0432.22469747.v1
Autor:
Kathleen Kelly, Eva Corey, William L. Dahut, Fatima H. Karzai, Aian Neil Alilin, JuanJuan Yin, Kerry M. McGowen, Qi Yang, Keith H. Jansson, Supreet Agarwal, Adam G. Sowalsky, Holly M. Nguyen, Crystal Tran, Caitlin M. Tice, Michael L. Beshiri
Supplementary Tables
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a288d02ce860b1ab59060cc0aa255dd2
https://doi.org/10.1158/1078-0432.22469738
https://doi.org/10.1158/1078-0432.22469738
Autor:
Kathleen Kelly, Eva Corey, William L. Dahut, Fatima H. Karzai, Aian Neil Alilin, JuanJuan Yin, Kerry M. McGowen, Qi Yang, Keith H. Jansson, Supreet Agarwal, Adam G. Sowalsky, Holly M. Nguyen, Crystal Tran, Caitlin M. Tice, Michael L. Beshiri
Somatic mutations in organoids and PDXs determined by WES
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7201fce75cae4a692b739074bdd44493
https://doi.org/10.1158/1078-0432.22469741.v1
https://doi.org/10.1158/1078-0432.22469741.v1
Autor:
Kathleen Kelly, Eva Corey, William L. Dahut, Fatima H. Karzai, Aian Neil Alilin, JuanJuan Yin, Kerry M. McGowen, Qi Yang, Keith H. Jansson, Supreet Agarwal, Adam G. Sowalsky, Holly M. Nguyen, Crystal Tran, Caitlin M. Tice, Michael L. Beshiri
Purpose: Prostate cancer translational research has been hampered by the lack of comprehensive and tractable models that represent the genomic landscape of clinical disease. Metastatic castrate-resistant prostate cancer (mCRPC) patient-derived xenogr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07784e4dbc8b75eb56d8f3cf0444f14f
https://doi.org/10.1158/1078-0432.c.6527324
https://doi.org/10.1158/1078-0432.c.6527324
Autor:
Margaret E Gatti-Mays, Nicholas P Tschernia, Julius Strauss, Ravi A Madan, Fatima H Karzai, Marijo Bilusic, Jason Redman, Houssein Abdul Sater, Charalampos S Floudas, Nicole J Toney, Renee N Donahue, Caroline Jochems, Jennifer L Marté, Deneise Francis, Sheri McMahon, Elizabeth Lamping, Lisa Cordes, Jeffrey Schlom, James L Gulley
Publikováno v:
Oncologist
Background NHS-IL12 is a first-in-class, recombinant fusion protein composed of the human monoclonal antibody NHS76 (binds exposed DNA/histones at sites of intratumoral necrosis) fused to 2 IL-12 heterodimers. The maximum tolerated dose (MTD) and rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a7630a6ed7d16e5f1ab6fdbfdf5cbb3
https://europepmc.org/articles/PMC10078919/
https://europepmc.org/articles/PMC10078919/
Autor:
Michael L. Beshiri, Brian J. Capaldo, Ross Lake, Anson T. Ku, Danielle Burner, Caitlin M. Tice, Crystal Tran, Julianna Kostas, Aian Neil Alilin, JuanJuan Yin, Supreet Agarwal, Samantha A. Morris, Fatima H. Karzai, Tamara L. Lotan, William L. Dahut, Adam G. Sowalsky, Kathleen Kelly
SUMMARYTo resist lineage-dependent therapies, cancer cells adopt a plastic stem-like state, leading to phenotypic heterogeneity. Here we dissect the cellular origins of such heterogeneity in a metastatic castration-resistant prostate cancer (CRPC) pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::35ec822d77262605fc0fe2c8e9d5dacf
https://doi.org/10.1101/2022.03.24.484651
https://doi.org/10.1101/2022.03.24.484651
Autor:
Fatima H, Karzai, Andrea B, Apolo, Liang, Cao, Ravi A, Madan, David E, Adelberg, Howard, Parnes, David G, McLeod, Nancy, Harold, Cody, Peer, Yunkai, Yu, Yusuke, Tomita, Min-Jung, Lee, Sunmin, Lee, Jane B, Trepel, James L, Gulley, William D, Figg, William L, Dahut
Publikováno v:
BJU international. 116(4)
TRC105 is a chimeric immunoglobulin G1 monoclonal antibody that binds endoglin (CD105). This phase I open-label study evaluated the safety, pharmacokinetics and pharmacodynamics of TRC105 in patients with metastatic castration-resistant prostate canc
Publikováno v:
Chemical immunology and allergy. 99
Prostate cancer is the most common cancer in men in the United States and is the second most common cause of death. While treatment options in early stage disease are curative in intent, treatment of metastatic prostate cancer remains challenging. Al
Autor:
Fatima H Karzai, Andrea Borghese Apolo, David E. Adelberg, Ravi Amrit Madan, James L. Gulley, Philip M. Arlen, Howard L. Parnes, Ann Pierpoint, David R. Kohler, Douglas K. Price, Seth M Steinberg, Jane B. Trepel, William Douglas Figg, William L. Dahut
Publikováno v:
Journal of Clinical Oncology. 30:117-117
117 Background: Preclinical and clinical evidence demonstrates an important role for angiogenesis in mCRPC biology. CD105 (endoglin) is a transmembrane protein expressed on the surface of proliferating vascular endothelial cells. The expression of CD